)
Visual
test
Onward Medical
Onward Medical (ONWD) investor relations material
Onward Medical Life Sciences Virtual Investor Forum 2025 summary
Complete event summary combining all related documents: earnings call transcript, report, and slide presentation.Life Sciences Virtual Investor Forum 2025 summary11 Dec, 2025
Market need and company vision
Spinal cord injury affects 9 million globally, with high lifetime care costs exceeding $5 million per tetraplegic patient.
Technologies aim to restore hand function, mobility, and independence for those with spinal cord injuries.
Three platforms: ARC-EX (external stimulator), ARC-IM (implanted system), and ARC-BCI (brain-computer interface) at various development stages.
Over 10 FDA Breakthrough Device Designations and 150+ patents issued worldwide.
Strategic investors include Ottobock and the Christopher Reeve Foundation.
Technology platforms and clinical progress
ARC-EX is commercially available in the US and Europe, targeting hand function with a global TAM of $8 billion.
Pivotal study showed 90% improved strength/function, 87% reported better quality of life, with benefits seen up to 34 years post-injury.
ARC-IM, a fully implanted system, is in pivotal trials for blood pressure instability, showing positive results in all 14 initial patients.
ARC-BCI enables thought-driven movement restoration; five humans have been implanted, with US clinical trials planned in 2–3 years.
BCI technology secured exclusive rights and received FDA Breakthrough Device status.
Commercialization, sales, and reimbursement
Over 70 ARC-EX systems sold to 60+ US clinics by Q3, with strong ongoing demand and thousands of inbound inquiries.
US go-to-market strategy leverages a consultative sales team of therapists, focusing on 500 specialized clinics.
Initial reimbursement targets VA, workers' comp, and self-pay, with Medicare coverage planned after real-world data is established.
Revenue expected at $6–6.5 million in year one, rising to mid-teens (millions) in year two.
Company is fully funded for 2026 milestones, with runway into 2027 after a €50 million financing round.
Partial view of Summaries dataset, powered by Quartr API
Research faster. Power your platform.
Latest summaries
- TimeTickerHeadlineOpen
- IQV
Strong Q4 and 2025 results with positive 2026 outlook and strategic segment realignment. - OWL
AUM reached $307.4 billion in 2025 amid record fundraising and double-digit earnings growth. - EMBC
Revenue was stable, net income rose, and leverage improved, with guidance reaffirmed. - VCTR
Q4 revenue up 61% YoY, $317B AUM, 52.8% EBITDA margin, and robust global expansion. - TW
Record revenue, strong earnings, and digital asset expansion drive robust results. - WEC
Adjusted EPS up 8% to $5.27; 2026 guidance and dividend growth reaffirmed. - VCTRQ1 saw higher revenue, Amundi deal closed, and dividend raised to $0.49 per share.
- MINDACORP
Record revenue and profit growth, margin expansion, and strong outlook amid regulatory changes. - SLQT
Q2 FY2026 revenue up 12% YoY, net income $69.3M, guidance revised for partner headwinds. - NATH
Revenue up, profits down; merger at $102/share and multiple dividends announced.
Next Onward Medical earnings date
Q4 202527 Mar, 2026
Onward Medical
Next Onward Medical earnings date
Q4 202527 Mar, 2026
The essential earnings season companion
The #1 app for qualitative research. Live earnings calls, AI chat, transcripts, and more. All for free.
Live calls and transcripts
Listen to earnings calls, CMDs, investor conferences, and more – with a podcast-like experience.
Find what you need faster
Search for any keyword across all transcripts simultaneously.
Easily store key findings
Capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Your watchlist. Your dashboard.
Follow the companies that matter to you. Get a personalized feed with real-time updates.
Be the first to know
Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned.
Consensus estimates
Access analyst consensus estimates, valuation multiples, and revenue segments splits.
All IR material in one place
The easiest way to stay updated during earnings season.
Global coverage
All events from public companies. Live and recorded.
Just click and listen
No webcast links. No manual registrations.
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
)
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
)
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
excellent app, it gives me free access to company earnings calls and annual reports. I also love the convenience of calls being available offline so I can listen in whilst doing other things and even when internet or WiFi isn't available.
Leroy DaleyApp Store
One of the very few apps you could call perfect. If something was to add to it, maybe the share price of the company when you search for it, but it's already excellent.
Eferix Drawings Google Play
This is genuinely one of the cleanest and fastest finance apps out there to track the market.
anuj283App Store
I can't remember the last time an app had such a positive impact on my investment process.
)
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
I can't remember the last time an app had such a positive impact on my investment process.
@ankurshah47_ x.com
Love the app! Quartr makes it really easy to keep track of earnings calls. It also includes the reports and slides to make it easier to follow along.
Amina0781App Store
Quartr is amazing, no way around it. It is the best right now for earnings calls, presentations, and the like.
@theshortbearx.com
)
)
Frequently asked questions
Onward Medical N.V. is a medical technology company focused on developing innovative therapies to restore movement, function, and independence for people with spinal cord injuries. It has developed two main technology platforms: ARCIM, an implantable neurostimulation system, and ARCEX, a non-invasive transcutaneous system. These technologies are designed to improve or restore motor functions and independence in individuals affected by spinal cord injuries through targeted spinal cord stimulation. The company is engaged in ongoing clinical trials to validate and expand the application of its technologies. Onward Medical N.V. is headquartered in Eindhoven, Netherlands, and its shares are listed on Euronext Brussels and Euronext Amsterdam.
Quartr provides global coverage of all investor relation material from public companies.
Mobile app: Research anytime, anywhere with the #1 app for live earnings calls, transcripts, analyst estimates, and more. All for free.
Desktop (Quartr Pro): The leading platform for qualitative research, used daily by top firms and financial institutions.
Quartr API: Build custom solutions powered by live earnings calls, live transcripts, filings and reports, slide presentations, and more.
Yes, the Quartr mobile app is free on both iOS and Android.
Yes. Quartr provides global, industry-leading live coverage of company events such as regular earnings calls, capital markets days, M&A announcements, and investor conferences. Live with zero delays. Just click and listen.
Yes, capturing important takeaways is as simple as it gets. Even during your lunch run or commute.
Yes. Follow the companies that matter to you. Get a personalized feed with real-time updates, a tailored earnings calendar, and instant alerts when earnings calls go live.
Yes. Set keyword alerts for any company, product, or competitor. Get notified the moment they're mentioned, regardless of who's talking.
Explore our global coverage